VOLUME 62   2001   NUMBER 10

CME Pretest 746

CME Posttest 834

Brainstorms

747 "Hit-and-Run" Actions at Dopamine Receptors, Part 2: Illustrating Fast Dissociation From Dopamine Receptors That Typifies Atypical Antipsychotics. Stephen M. Stahl
[PDF]

Original Articles

749 Service Use and Costs of Treating Schizophrenia With Atypical Antipsychotics. Michael Lewis, Paul McCrone, and Sophia Frangou
[Abstract] [PDF]

757 The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials. John M. Davis and Nancy Chen
[Abstract] [PDF]

772 Treatment of Tardive Dyskinesia With Donepezil: A Pilot Study. Stanley N. Caroff, E. Cabrina Campbell, Joan Havey, Kenneth A. Sullivan, Stephan C. Mann, and Robert Gallop
[Abstract] [PDF]

776 Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients? Madhukar H. Trivedi, A. John Rush, Thomas J. Carmody, Rafe M. J. Donahue, Carolyn Bolden-Watson, Trisha L. Houser, and Alan Metz
[Abstract] [PDF]

782 Efficacy of Mirtazapine for Prevention of Depressive Relapse: A Placebo-Controlled Double-Blind Trial of Recently Remitted High-Risk Patients. Michael E. Thase, Andrew A. Nierenberg, Martin B. Keller, and John Panagides for the Relapse Prevention Study Group
[Abstract] [PDF]

789 An Open-Label, 12-Week Clinical and Sleep EEG Study of Nefazodone in Chronic Combat-Related Posttraumatic Stress Disorder. J. Christian Gillin, Alison Smith-Vaniz, Bradley Schnierow, Mark H. Rapaport, John Kelsoe, Eric Raimo, Matthew R. Marler, Lorraine M. Goyette, Murray B. Stein, and Sidney Zisook
[Abstract] [PDF]

797 Association of Depressive Symptoms With Worse Functioning in Schizophrenia: A Study in Older Outpatients. [CME] Hua Jin, Sidney Zisook, Barton W. Palmer, Thomas L. Patterson, Robert K. Heaton, and Dilip V. Jeste
[Abstract] [PDF]

804 Suicide in Primary Affective Disorders Revisited: A Systematic Review by Treatment Era. [CME] Denis O'Leary, Eugene Paykel, Chris Todd, and Katerina Vardulaki
[Abstract] [PDF]

812 Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability. Hsien-Yuan Lane, Michael W. Jann, Yue-Cune Chang, Chih-Chiang Chiu, Ming-Chyi Huang, Sue-Hong Lee, and Wen-Ho Chang
[Abstract] [PDF]

818 Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders: Results From a 6-Month, Multicenter, Open Study. Eduard Vieta, Jose M. Goikolea, Barbara Corbella, Antonio Benabarre, Maria Reinares, Guadalupe MartĚnez, Antonio Fernandez, Francesc Colom, Anabel Martinez-Aran, and Carla Torrent for the Group for the Study of Risperidone in Affective Disorders (GSRAD)
[Abstract] [PDF]

Letters To the Editor

826 Mean Dose After Splitting Sertraline Tablets. Paul R. Matuschka and James B. Graves
[PDF]

826 Lamotrigine in the Treatment of Depersonalization Disorder. Mauricio Sierra, Mary L. Phillips, Michelle V. Lambert, Carl Senior, Antony S. David, and John H. Krystal
[PDF]

828 Olanzapine Versus Other Antipsychotics in the Treatment of Schizophrenia. Prakash S. Masand
[PDF]

  • Reply by Jose A. Sacristan and Juan Carlos Gomez

829 Should We Keep Calling Antidepressants Antidepressants? Diogo R. Lara and Diogo O. Souza
[PDF]

  • Reply by Alan F. Schatzberg

Book Reviews 831

NOW @ Psychiatrist.com 836

Information for authors

see July 2001, pages 579-581 or our Web site at www.psychiatrist.com/author.htm